Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a plasma boost make dental implants hold stronger?

NCT ID NCT07744776

Disease control Sponsor: Dantu implantologijos centras Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Sep 09, 2026 · Updated 2 times

Summary

This trial compares different dental implant designs and surface treatments to see how they affect early stability in the jawbone. Fifty adults needing a single implant in the lower back jaw will be randomly assigned to one of five implant types, including some with a special plasma-activated surface. The study measures how tightly the implant fits at placement and how stability changes over six weeks, aiming to find which combination offers the best start for long-term success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dental implants with different macro-designs and surface treatments, including chairside plasma activation (XActive) and manufacturer surfaces (SLA, SLActive, Xpeed).
What this could lead to
If successful, this could help dentists choose implant designs and surface treatments that improve early stability, potentially reducing implant failure and speeding up recovery.
What could go wrong
This is a small pilot study, so results may not be conclusive. The findings might not apply to all patients or implant types, and the treatments are only tested for early stability, not long-term success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Requiring a dental implant in a healed mandibular molar site (≥ 3 months post-extraction) * Site anatomy suitable for placement of a 4.1 × 10 mm implant * Bleeding on probing \< 20% * Plaque index \< 25% Exclusion Criteria: * Smoking ≥ 10 cigarettes/day * History of uncontrolled periodontitis * Uncontrolled diabetes * Alcoholism * Use of medication known to impair bone healing

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dental implant macrodesign are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dental implant macrodesign Dental implant primary stability Dental implant secondary stability Dental implant stability quotient (ISQ) Dental implant surface treatment Effects of dental implant macrodesign and surface treatment on primary and secondary stability

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dantu implantologijos centras

    RECRUITING

    Vilnius, 08216, Lithuania